State Board Of Administration Of Florida Retirement System Immuno Gen, Inc. Transaction History

State Board Of Administration Of Florida Retirement System

$51.5 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$14.09 - $19.87 $4,086 - $5,762	290 Added 0.42%	69,187 $1.1 Million
Q2 2023 Aug 11, 2023	SELL	$3.75 - $20.05 $5,587 - $29,874	-1,490 Reduced 2.12%	68,897 $1.3 Million
Q4 2022 Feb 07, 2023	SELL	$4.55 - $6.31 $32,305 - $44,801	-7,100 Reduced 9.16%	70,387 $349,000
Q4 2021 Feb 08, 2022	BUY	$4.75 - $7.5 $807 - $1,275	170 Added 0.22%	77,487 $575,000
Q2 2021 Aug 10, 2021	BUY	$5.79 - $8.6 $521 - $774	90 Added 0.12%	77,317 $510,000
Q1 2020 May 05, 2020	SELL	$2.12 - $6.8 $551 - $1,768	-260 Reduced 0.34%	77,227 $263,000
Q2 2018 Aug 06, 2018	BUY	$9.52 - $12.15 $1,904 - $2,430	200 Added 0.26%	77,487 $754,000
Q1 2018 May 04, 2018	SELL	$6.7 - $12.95 $25,145 - $48,601	-3,753 Reduced 4.63%	77,287 $813,000
Q3 2017 Oct 31, 2017	BUY	$5.4 - $8.47 $437,616 - $686,408	81,040	81,040 $620,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.

Account